The Lesions You Do Not Fire On: Where Pigment Work Stops

Most pigmented lesions that walk into a laser clinic are benign. Sunspots. Freckles. Nevus of Ota, stable lentigines. Q-switched 532 nm and 1064 nm pulses handle all of them well. Your first decision isn't pulse duration, though, and it isn't fluence. You're deciding whether to fire at all. Below: the hard stop criteria, how laser energy wrecks a clean pathology read later, and the wording your referral note needs.

The first filter is morphology, not depth

Wavelength and spot size follow depth. Our archive splits dermal from epidermal pigment for exactly that reason, and you can see the logic in our nevus of Ota protocol and our freckle removal guide. Depth is a planning tool. Nothing more. It won't tell you whether a lesion is safe to touch.

Melanoma sits in the epidermis, in the dermis, or in both. Nevus of Ota sits deep and treats well once cleared. A superficial dysplastic nevus may still be dangerous. So morphology outranks depth. Always.

What suspicious morphology looks like in the room

• Asymmetry: one half doesn't match the other.
• Border irregularity: scalloped edges, notched edges, fuzzy edges.
• Color variation: two or more shades of brown, black, red, white, or blue inside one lesion.
• Diameter increase: any measurable growth between visits, however small.
• Recent change: new itch, bleeding, crusting, or a nodule rising inside a spot that used to be flat.

One feature is enough. You don't need all five, and waiting for a second one to appear is how spots get missed. Never use the laser to tidy a suspicious edge. Don't spot-test it either. A single pulse leaves thermal artifact. Weeks later, that artifact can confuse a pathologist.

What to do in the first 60 seconds

Stop the treatment. Photograph the lesion with a ruler and decent light. Write down location, size, color, and any symptom the patient mentions, then name the specific feature that bothered you. Now say the sentence you'll reuse every time: This spot has features I want a dermatologist to evaluate before any light-based treatment. It is probably harmless, but we cannot treat it safely until that is confirmed.

Lesions that never get fired on in our facility

The list is short. Memorize it. Congenital melanocytic nevi. Spitz-like lesions. Anything with a recent change. All three go straight to referral. Your eye alone is not the instrument here. Referral isn't a failure of clinical skill. It's the only defensible move you have.

Congenital nevi and Spitz-like lesions

Congenital melanocytic nevi show up at birth or in the first months of life. Small ones are common. Medium and large ones carry a lifetime risk of change, and laser isn't first line for any of them. Why? It lightens pigment without removing the cells, which leaves a muddled background for whoever does surveillance later. Spitz-like lesions are the other trap: pink, tan, or brown papules that can read as a Spitz nevus or as a melanoma under a dermatoscope. No Q-switched handpiece tells those apart. Refer both.

Changed in the last six months? Same stop, whatever it looked like before. A previously stable mole that starts itching, bleeding, or growing has stopped being a laser target. Patients will tell you it has always looked like that. They say it because nobody asked the right question. Ask whether it changed recently.

Why firing changes the pathology you need later

Nanosecond pulses. That's what a Q-switched laser delivers, and they shatter pigment particles, which is exactly what you want on a benign tattoo. Point the same pulse at a suspicious melanocytic lesion and you disrupt cell architecture and set off inflammation. Biopsy that site afterward. The slide comes back with thermal damage, pigment incontinence, and fibrosis. Your pathologist may not be able to say whether atypical cells were there before your pulse or appeared because of it. You've destroyed the evidence. StatPearls summaries on laser treatment of pigmented lesions note that fluence and pulse width selection assume a confirmed benign diagnosis first.

Picture a crime scene. You're about to hose down a fingerprint because the floor looked dirty. If the lesion turns out to be melanoma, clean margins and intact cellular detail are what everyone downstream works from. Your laser can't tell benign from malignant. It breaks pigmented cells, full stop. When in doubt, don't fire. Let the biopsy blade answer the question.

Referral script and documentation: what your chart needs

Three minutes. That's what a good referral costs you. It protects the patient, and it protects your license. Here's the flow.

Chart language that protects your practice

Write what you saw, not what you suspect. Skip diagnoses like possible melanoma. Morphology instead: asymmetric, 6 mm, brown-black with irregular border on left forearm. Treatment deferred. Dermatology referral provided. Patient refuses to go? Document that as well. Patient declined referral, advised of risk, will return if changes. And don't quietly treat them a month later unless a dermatology clearance letter is sitting in the chart.

Patient-facing wording that reduces pushback

Some patients argue. They want the spot gone today, and they will push. Keep your sentences short. I understand you want it removed. But I see a feature that worries me. A laser can hide the problem, not fix it. I want a dermatologist to look first. After that, if it is clear, we can talk about treatment. Still demanding the laser? You say no. This isn't a negotiation.

Where laser pigment work actually belongs: cleared lesions only

Once a dermatologist clears the lesion, plan by depth and chromophore. Benign epidermal pigmentation such as freckles and lentigines usually answers to a 532 nm Q-switched pulse. Dermal pigment is a different job. Nevus of Ota needs 1064 nm, the workhorse. Our QN-03 Q-switched ND:YAG system delivers both wavelengths with short pulse durations, which is why a list of cleared indications hangs on our wall. No parameter set makes an unsafe lesion safe.

If you do treat, which parameters matter first

Start low. Maximum fluence is not an opening move. Test a spot on a hidden part of the lesion where you can, or on similar normal skin when the lesion is too small for that. Watch for the immediate whitening endpoint. Then stop. How confident you feel has nothing to do with the right fluence; lesion depth and skin type do. Reach for a Woods lamp or a dermoscope to estimate melanin depth before you choose between 532 nm and 1064 nm. Navya and Pai, Indian Dermatology Online Journal, 2022 showed both tools help localize melanin depth in melasma, and the same logic carries over to benign pigmented lesions. Depth assessment still comes after morphology clearance. Never before.

Compliance boundary: your role is selection, not diagnosis

You're an operator with a laser. Not a pathologist. Filtering is the job; diagnosing isn't. Every staff member should know the stop features cold, so tape a laminated ABCDE card beside the laser and run a morning checklist: asymmetry, border irregularity, color variation, diameter change, evolution. Any one of those and the patient gets referred. No sales target changes that rule. A cleared nevus of Ota patient can be a great result. A missed melanoma ends careers.

Want our device parameters and treatment protocols? They live in the product archive and the solution pages. Building a referral network starts with a conversation, and our contact page is where you begin.